Vertex Pharmaceuticals · 3 days ago
Director, Pain, Global Value & Access Strategy
Boston, MA
Full-time
Hybrid
Director/Executive
$201K/yr - $302K/yr
8+ years expVertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. The Director, Pain, Global Value & Access Strategy role will serve as Market Access Lead for the chronic indications across the Pain portfolio, focusing on developing Global Market Access strategies and co-leading the Global Commercial Team.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Responsible for Global payer strategic planning to support value and access optimization for chronic indications (DPN/LSR/PNP) for suzetrigine as well as the broader Pain portfolio
Lead development of Market Access strategies and core Global P&R deliverables operating within the cross-functional, cross-regional commercialization process
Responsible for Global payer strategic planning to support value and access optimization; lead development of Global Payer Plan which integrates value evidence generation, strategic pricing, value communications, stakeholder engagement to support successful reimbursement and pricing
Accountable for ensuring that payer and market access perspectives are reflected in all cross-functional strategies (e.g. commercial, product development, regulatory affairs)
Ensure identification and prioritization of all evidence required to capture value, support a differentiated target product profile (TPP), and ensure local pricing and access
Support strategies with deep functional knowledge, in-depth market research, environmental data & analogs
Inform financial forecasts
Partner with Health Economics & Outcomes Research (HEOR), Real-World Evidence (RWE) and Global Marketing to ensure robust value proposition and integrated evidence plans are optimized to support global market access and reimbursement
Co-lead the Pain Global Commercial Team, and work cross-functionally and cross-regionally to develop optimal commercial strategies
The Global Commercial Team facilitates development of a commercial strategy in order to maximize the lifetime value of the asset globally; is the primary hub for alignment and input into the Disease Strategy Team
This role should ensure collaboration and drive alignment across Global Commercial Team and leadership to integrate market access strategy and ensure resourcing for commercial success
Support P&MA capability building and thought leadership projects that advance knowledge of and readiness for the rapidly evolving Global payer environment
Maintain industry awareness and proactively address changes in market trends, competition, product acceptance and new product releases and adjust Market Access plans accordingly
Collaborate closely with HEOR, International P&R, Corporate Affairs, US Market Access, Countries, Marketing and Clinical Development counterparts to ensure value and access optimization
Qualification
Required
Deep working knowledge of both US and ex-US healthcare systems required; experience in comparable Global role considered a plus
Experience in leading cross-functional teams required
Demonstrated ability to think strategically and make sound pricing and market access recommendations
Entrepreneurial, energetic, dynamic, enthusiastic, decisive, and self-motivated; possesses a sense of urgency with the ability and strong desire to 'make things happen'
Strong practical, quantitative and analytical skills combined with a sound understanding of how to successfully apply pricing & reimbursement / HEOR principles to support Vertex
General experience in commercialization and drug development
Exhibits outstanding written and oral communication skills, including the ability to effectively write and deliver presentations to professionals at all levels within Vertex
Demonstrated relationship building at all levels of the organization and across geographies
Recognized as a team player with excellent interpersonal skills who is flexible and reliable
Displays sound ethics and a fit for Vertex's core values
Bachelor's degree in relevant discipline requiring quantitative analysis; advanced degree preferred
Typically requires 8 years of experience or the equivalent combination of education and experience
Preferred
Experience in specialty and/or rare disease access models
Benefits
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
5001-10000 employees
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Reshma Kewalramani
CEO and President
Nina Devlin
Senior Vice President, Chief Communications Officer
Recent News
2026-01-13
2026-01-12
Company data provided by crunchbase